Prostate cancer radiation cut from 48 to 5 sessions in new trial

NCT ID NCT00911118

First seen May 20, 2026 · Last updated May 24, 2026 · Updated 1 time

Summary

This study tested a new type of radiation therapy for low- and intermediate-risk prostate cancer that delivers a higher dose each day, reducing total treatments from 45-48 to just 5 over 2 weeks. 120 participants received this ultra-hypofractionated, image-guided radiotherapy. The main goal was to check safety and side effects, with additional monitoring of PSA levels, biopsy results, and sexual function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Memorial Sloan Kettering Cancer Center @ Suffolk

    Commack, New York, 11725, United States

  • Memorial Sloan Kettering Cancer Center@Phelps

    Sleepy Hollow, New York, United States

  • Memorial Sloan Kettering Nassau

    Uniondale, New York, 11553, United States

  • Memorial Sloan Kettering West Harrison

    Harrison, New York, 10604, United States

  • Memorial Sloan Kettering at Mercy Medical Center

    Rockville Centre, New York, United States

  • Montefiore Medical Center

    The Bronx, New York, 10467, United States

Conditions

Explore the condition pages connected to this study.